Welcome to YLOAN.COM
yloan.com » Health » Imbalance in Postdiscontinuation Chemotherapy and Mesothelioma Disease
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Imbalance in Postdiscontinuation Chemotherapy and Mesothelioma Disease

Another interesting study is called, "Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis" by S

. Shetty, A. Kumar, A. Johnson, S. Pueblitz and S. Idell - Department of Medicine, University of Texas Health Science Center at Tyler 75710, USA. Am J Physiol Lung Cell Mol Physiol 268: L972-L982, 1995. Here is an excerpt: "Urokinase (uPA) interacts with its receptor (uPAR) to promote proteolysis and tumor migration, functions of potential importance in the pathogenesis of malignant mesothelioma. Immunohistochemistry of human malignant mesothelioma tissue and mesothelioma cells (MS-1) showed that mesothelioma cells express uPAR. We isolated uPAR from MS-1 cells by metabolic labeling and showed that it could be induced by phorbol myristate acetate (PMA), lipopolysaccharide (LPS), a transforming growth factor-beta (TGF-beta) or tumor necrosis factor-alpha (TNF-alpha). Experiments with MS-1 cells showed that uPA binding was saturable, specific, and reversible with a mean dissociation constant (Kd) of 5.4 +/- 1.1 nM. Binding was inhibited by a blocking antibody to uPAR and by the uPA amino-terminal fragment (ATF), but not by low molecular weight uPA. uPAR expression was regulated transcriptionally and translationally; antisense oligonucleotides blocked expression of uPAR protein. Plasminogen activator inhibitor-1 (PAI-1) inhibited PA activity of preformed uPA/uPAR complexes and increased cycling of the receptor from the cell surface. Stimulation of subconfluent MS-1 cells by high molecular weight or recombinant uPA, but not ATF or low molecular weight fragment, caused concentration-dependent incorporation of [3H]thymidine. These data indicate a novel mechanism by which malignant mesothelioma cells localize pericellular proteolysis and concurrently regulate tumor cell proliferation."

Imbalance in Postdiscontinuation Chemotherapy and Mesothelioma Disease

By: Montwrobleski77
Ameliorating Treatment for Mesothelioma Disease 6 Tips on the Benefits of a Sea Salt Colon Cleanse How To Build Up Your Health and Vitality Basal Body Temperature Charting: What is it and why should you do it? Tips - Improving Sex For Couples - Obtaining A Healthy Sex Lifestyle Proven - Boost Sexual Desire With Chinese Sex Herbs Get Up, Get Out There, And Get Your Life Back! FREE Healthy eNews From Father Time! Look And Feel Better... Soon! New Facts - The Effect Of Diabetes On Men'S Sexual Health Turn Off The TV And Get Outdoors And Get YOUR LIFE Back! FREE Healthy eNews To Help You Along! Is Natural Male Enhancement Is safe for your health Ecigarettes a healthier form of smoking? Not Really but they are cool!! Maintaining A Healthy Relationship: Three Easy Ways To Succeed Endometriosis Surgeon - Freezing Nails
print
www.yloan.com guest:  register | login | search IP(216.73.216.232) California / Anaheim Processed in 0.017123 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 4 , 1973, 61,
Imbalance in Postdiscontinuation Chemotherapy and Mesothelioma Disease Anaheim